Biocon Biologics and Civica Team Up to Break Insulin Price Barriers in the U.S.

Biocon Biologics Ltd., a subsidiary of India’s Biocon Ltd., has deepened its collaboration with U.S.-based nonprofit Civica Inc. to roll out a private-label version of insulin glargine in the United … Read more